Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Linde
LIN
|
+$764M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$574M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$418M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$344M |
| 5 |
UnitedHealth
UNH
|
+$284M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.28B |
| 2 |
Shopify
SHOP
|
+$370M |
| 3 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$351M |
| 4 |
Microsoft
MSFT
|
+$326M |
| 5 |
RP
RealPage, Inc.
RP
|
+$316M |
Sector Composition
| 1 | Technology | 16.42% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.02% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EBAC
3376
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
| $1.45M | ﹤0.01% |
+149,015
| New | +$1.45M |
|
3377
DHI Group
DHX
$140M
| $1.45M | ﹤0.01% |
+428,280
| New | +$1.45M |
|
3378
908 Devices
MASS
$236M
| $1.45M | ﹤0.01% |
37,351
-136,911
| -79% | -$5.3M |
|
|
HCCCU
3379
DELISTED
Healthcare Capital Corp. Unit
HCCCU
| $1.45M | ﹤0.01% |
145,000
-15,000
| -9% | -$150K |
|
3380
AbCellera Biologics
ABCL
$1.37B
| $1.44M | ﹤0.01% |
65,657
+41,269
| +169% | +$908K |
|
|
ATHX
3381
DELISTED
Athersys, Inc. Common Stock
ATHX
| $1.44M | ﹤0.01% |
+40,113
| New | +$1.44M |
|
3382
Aqua Metals
AQMS
$5.57M
| $1.44M | ﹤0.01% |
2,395
-1,355
| -36% | -$813K |
|
3383
First Internet Bancorp
INBK
$210M
| $1.43M | ﹤0.01% |
46,278
+28,701
| +163% | +$889K |
|
|
BIOTU
3384
DELISTED
Biotech Acquisition Company Unit
BIOTU
| $1.43M | ﹤0.01% |
142,280
| – | – |
|
3385
BRF SA
BRFS
$6.7B
| $1.43M | ﹤0.01% |
260,875
-2,223,202
| -89% | -$12.2M |
|
3386
Alpha Pro Tech
APT
$50.1M
| $1.43M | ﹤0.01% |
+166,272
| New | +$1.43M |
|
3387
Apyx Medical
APYX
$83.2M
| $1.42M | ﹤0.01% |
137,963
+118,785
| +619% | +$1.22M |
|
3388
PG&E
PCG
$33.2B
| $1.42M | ﹤0.01% |
139,536
-1,871,139
| -93% | -$19M |
|
3389
Manchester United
MANU
$2.62B
| $1.42M | ﹤0.01% |
93,351
+21,850
| +31% | +$332K |
|
|
WARR
3390
DELISTED
Warrior Technologies Acquisition Company
WARR
| $1.42M | ﹤0.01% |
+146,525
| New | +$1.42M |
|
3391
Alliance Entertainment
AENT
$347M
| $1.42M | ﹤0.01% |
+145,729
| New | +$1.42M |
|
3392
Exicure
XCUR
$22.4M
| $1.41M | ﹤0.01% |
6,283
+5,912
| +1,594% | +$1.33M |
|
|
BCLI
3393
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.41M | ﹤0.01% |
+24,764
| New | +$1.41M |
|
3394
Community Trust Bancorp
CTBI
$1.02B
| $1.41M | ﹤0.01% |
34,949
+7,506
| +27% | +$303K |
|
3395
Automatic Data Processing
ADP
$117B
| $1.41M | ﹤0.01% |
7,098
-10,358
| -59% | -$2.06M |
|
3396
Weyco Group
WEYS
$282M
| $1.41M | ﹤0.01% |
62,884
+45,592
| +264% | +$1.02M |
|
3397
Universal Technical Institute
UTI
$1.51B
| $1.41M | ﹤0.01% |
216,709
+194,013
| +855% | +$1.26M |
|
3398
Fox Class A
FOXA
$26.4B
| $1.4M | ﹤0.01% |
37,801
-250,662
| -87% | -$9.31M |
|
3399
Zentalis Pharmaceuticals
ZNTL
$102M
| $1.4M | ﹤0.01% |
26,368
-101,861
| -79% | -$5.42M |
|
3400
Paymentus
PAY
$4.4B
| $1.4M | ﹤0.01% |
+39,528
| New | +$1.4M |
|